S. S. Jhee

Pharmacokinetics and Pharmacodynamics of the Novel Daily Rivastigmine Transdermal Patch Compared With Twice-daily Capsules in Alzheimer's Disease Patients

Gilbert Lefèvre, G Sędek, S. S. Jhee et al. · Clinical Pharmacology & Therapeutics · 2007 · 130 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's disease

Neal R. Cutler, R. J. Polinsky, J. J. Srarnek et al. · Acta Neurologica Scandinavica · 2009 · 121 citations

Medicine, Neurology, Pharmacology +17

Low Penetration of Oseltamivir and Its Carboxylate into Cerebrospinal Fluid in Healthy Japanese and Caucasian Volunteers

S. S. Jhee, Mark Yen, Larry Ereshefsky et al. · Antimicrobial Agents and Chemotherapy · 2008 · 57 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Pharmacokinetic‐Pharmacodynamic Modeling of Rivastigmine, a Cholinesterase Inhibitor, in Patients with Alzheimer's Disease

Jogarao Gobburu, Vijay Tammara, Lawrence Lesko et al. · The Journal of Clinical Pharmacology · 2001 · 45 citations

Medicine, Pharmacokinetics, Pharmacology +17

Multiple‐Dose Plasma Pharmacokinetic and Safety Study of LY450108 and LY451395 (AMPA Receptor Potentiators) and Their Concentration in Cerebrospinal Fluid in Healthy Human Subjects

S. S. Jhee, Amy S. Chappell, Victoria Zarotsky et al. · The Journal of Clinical Pharmacology · 2006 · 32 citations

Medicine, Pharmacokinetics, Pharmacology +12